Immunomodulatory Changes Following Isolated RF Ablation in Colorectal Liver Metastases: A Case Report

Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer

Gastroenterology.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ

doi: 10.1053/j.gastro.2017.05.013.

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

Curr Colorectal Cancer Rep.

Christopher Coyle, Fay Helen Cafferty, and Ruth Elizabeth Langley

Gastrointestinal Cancer

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

J Surg Oncol.

Sho S, Court CM, Winograd P, Russell MM, Tomlinson JS

doi: 10.1002/jso.24781.

Gastrointestinal Cancer

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Clin Colorectal Cancer.

Masuishi T, Taniguchi H, Hamauchi S, Komori A, Kito Y, Narita Y, Tsushima T, Ishihara M, Todaka A, Tanaka T, Yokota T, Kadowaki S, Machida N, Ura T, Fukutomi A, Ando M, Onozawa Y, Tajika M, Yasui H, Muro K, Mori K, Yamazaki K

doi: 10.1016/j.clcc.2016.07.019.

Gastrointestinal CancerSkin Cancer

Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy

Cancer Biol Ther.

Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS

doi: 10.1080/

Gastrointestinal Cancer

Acrometastasis following colorectal cancer: A case report and review of literature

Int J Surg Case Rep.

Agha K, Akbari K, Abbas SH, Middleton S, McGrath D

doi: 10.1016/j.ijscr.2016.10.078

Gastrointestinal Cancer

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

JAMA Oncol.

Tomasello G, Petrelli F, Ghidini M, Russo A, Passalacqua R, Barni S

doi: 10.1001/

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study

JAMA Oncol.

Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, Castillo AL, Caan BJ

doi: 10.1001/

Gastrointestinal Cancer

Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes

Eur J Cancer.

Stintzing S, Tejpar S, Gibbs P, Thiebach L, Lenz HJ

doi: 10.1016/j.ejca.2017.07.016.

Related content

Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy

Acrometastasis following colorectal cancer: A case report and review of literature

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study

Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes